For purchasing or obtaining a quotation, please visit the Distributor page
to find your local distributor.
to find your local distributor.
HOME > Product search results
Searched by
Product（2328）
Kits（142）
Proteins（83）
Peptide（5）
Enzymes（7）
Vectors（17）
Reagents（63）
Substrates（1）
Inhibitors（4）
Racks（1）
Refine your search
[+]Animal species
[+]Category
[+]Conjugate
[+]MHC Allele
[+]Research area
[+]Tools
[+]Brands
[+]Availability (in Japan)
| Clip | Code No. | Product | Data | |||
|---|---|---|---|---|---|---|
| Data
Sheet |
Category | Conjugate | MHC Allele | Size | Availability | |
| Sequence | Location (aa) | Storage
temp. |
||||
|
|
||||||
|
TC-M704-2 |
T-Select I-Ab MOG35-55 Tetramer-APC |
|
|||
|
Others | APC | I-Ab | 20 tests |
0 (Contact us) |
|
| MEVGWYRSPFSRVVHLYRNGK | 35-55 | ４°C | ||||
|
|
TC-M802-4 |
HLA-DRB1*01:01 HIV gag295-307 Tetramer-DYVDRFYKTLRAE-BV421 |
|
|||
|
|
virus HIV |
BV421 | DRB1*01:01 | 20 tests |
0 (Contact us) |
|
| DYVDRFYKTLRAE | ４°C | |||||
|
|
TC-M818-1 |
HLA-DRB1*15:01 Bet v 1142-156 Tetramer-ETLLRAVESYLLAHS-PE |
|
|||
|
|
Others | PE | DRB1*15:01 | 20 tests |
0 (Contact us) |
|
| ETLLRAVESYLLAHS | 142-156 | ４°C | ||||
|
|
TC-M801-4 |
HLA-DRB1*01:01 human CLIP103-117 Tetramer-PVSKMRMATPLLMQA-BV421 |
|
|||
|
|
negative | BV421 | DRB1*01:01 | 20 tests |
0 (Contact us) |
|
| PVSKMRMATPLLMQA | 103-117 | ４°C | ||||
|
|
TC-M717-1 |
T-Select I-Ag7 human CLIP103-117 Tetramer-PE |
|
|||
|
|
negative | PE | Others | 20 tests |
0 (Contact us) |
|
| PVSKMRMATPLLMQA | 103-117 | ４°C | ||||
|
|
TC-8001-1 |
HLA-A*11:01 KRAS7-16 G12D Tetramer-VVVGADGVGK-PE |
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGADGVGK | 7-16 | ４°C | ||||
|
|
TC-8031-2 |
HLA-A*03:01 KRAS7-16 G12D Tetramer-VVVGADGVGK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGADGVGK | 7-16 | ４°C | ||||
|
|
TC-8004-1 |
HLA-A*11:01 KRAS8-16 G12V Tetramer-VVGAVGVGK-PE |
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGAVGVGK | 8-16 | ４°C | ||||
|
|
TC-8022-1 |
HLA-A*11:01 KRAS7-16 G12C Tetramer-VVVGACGVGK-PE |
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGACGVGK | 7-16 | ４°C | ||||
|
|
TC-8032-1 |
HLA-A*03:01 KRAS7-16 G12V Tetramer-VVVGAVGVGK-PE |
|
|||
|
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGAVGVGK | 7-16 | ４°C | ||||
|
|
TS-M250-1 |
HLA-A*02:01 EBV BRLF1 Tetramer-YVLDHLIVV-PE |
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YVLDHLIVV | 109-117 | ４°C | ||||
|
|
TC-8015-1 |
HLA-A*11:01 KRAS7-16 G13D Tetramer-VVVGAGDVGK-PE |
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAGDVGK | 7-16 | ４°C | ||||
|
|
TC-8023-2 |
HLA-A*11:01 KRAS7-16 G12S Tetramer- VVVGASGVGK-APC |
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGASGVGK | 7-16 | ４°C | ||||
|
|
TS-M202-2 |
HLA-A*01:01 NRAS Neoepitope Tetramer-ILDTAGREEY-APC |
|
|||
|
|
cancer | APC | A*01:01 | 50 tests |
0 (Contact us) |
|
| ILDTAGREEY | ４°C | |||||
|
|
TC-8002-2 |
HLA-A*11:01 KRAS8-16 G12D Tetramer-VVGADGVGK-APC |
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGADGVGK | 8-16 | ４°C | ||||
|
|
TC-8025-2 |
HLA-A*11:01 HPV16 E789-97 Tetramer-IVCPICSQK-APC |
|
|||
|
|
virus | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| IVCPICSQK | 89-97 | ４°C | ||||
|
|
TC-8011-2 |
HLA-A*02:01 KRAS5-14 G12V Tetramer-KLVVVGAVGV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVVVGAVGV | 5-14 | ４°C | ||||
|
|
TS-M252-1 |
HLA-A*03:01 PRPF6 Neoepitope Tetramer-KILDAVVAQK-PE |
|
|||
|
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| KILDAVVAQK | ４°C | |||||
|
|
TC-8016-2 |
HLA-A*11:01 EGFR852-860 L858R Tetramer-KITDFGRAK-APC |
|
|||
|
|
Others | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| KITDFGRAK | 852-860 | ４°C | ||||
|
|
TC-8029-2 |
HLA-A*03:01 KRAS8-16 G12C Tetramer-VVGACGVGK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVGACGVGK | 8-16 | ４°C | ||||
|
|
TC-8012-2 |
HLA-A*11:01 KRAS7-16 G12R Tetramer-VVVGARGVGK-APC |
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGARGVGK | 7-16 | ４°C | ||||
|
|
TC-8034-2 |
HLA-A*03:01 KRAS7-16 WT Tetramer-VVVGAGGVGK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGAGGVGK | 7-16 | ４°C | ||||
|
|
TS-M260-2 |
HLA-A*11:01 CDK13 Neoepitope Tetramer-CILGKLFTK-APC |
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| CILGKLFTK | ４°C | |||||
|
|
TS-M251-2 |
HLA-A*03:01 SIRT2 Neoepitope Tetramer-KIFSEVTLK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| KIFSEVTLK | ４°C | |||||
|
|
TS-M607-1 |
H-2Kb MCMV M38 Tetramer-SSPPMFRV-PE |
|
|||
|
|
virus | PE | H-2Kb | 50 tests |
0 (Contact us) |
|
| SSPPMFRV | 316-323 | ４°C | ||||
|
|
TC-8012-1 |
HLA-A*11:01 KRAS7-16 G12R Tetramer-VVVGARGVGK-PE |
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGARGVGK | 7-16 | ４°C | ||||
|
|
TS-M601-1 |
H-2Db CV-B polyprotein Tetramer-FHAGSLLVFM-PE |
|
|||
|
|
virus | PE | H-2Db | 50 tests |
0 (Contact us) |
|
| FHAGSLLVFM | 268-277 | ４°C | ||||
|
|
TC-8021-2 |
HLA-A*11:01 KRAS7-16 G12A Tetramer-VVVGAAGVGK-APC |
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAAGVGK | 7-16 | ４°C | ||||
|
|
TS-M254-1 |
HLA-A*03:01 MYO1B Neoepitope Tetramer-KINKNPKYK-PE |
|
|||
|
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| KINKNPKYK | ４°C | |||||
|
|
TS-M603-2 |
H-2Db MuHV-4 ORF6 Tetramer-AGPHNDMEI-APC |
|
|||
|
|
virus | APC | H-2Db | 50 tests |
0 (Contact us) |
|
| AGPHNDMEI | 487-495 | ４°C | ||||
|
|
TC-8029-1 |
HLA-A*03:01 KRAS8-16 G12C Tetramer-VVGACGVGK-PE |
|
|||
|
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVGACGVGK | 8-16 | ４°C | ||||
|
|
TS-M263-2 |
HLA-A*11:01 Perilipin-2 Tetramer-TSALPIIQK-APC |
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| TSALPIIQK | 63-71 | ４°C | ||||
|
|
TS-M201-1 |
HLA-A*01:01 TRIP12 Neoepitope Tetramer-PSDTRQMLFY-PE |
|
|||
|
|
cancer | PE | A*01:01 | 50 tests |
0 (Contact us) |
|
| PSDTRQMLFY | ４°C | |||||
|
|
TC-8005-1 |
HLA-A*11:01 KRAS8-16 WT Tetramer-VVGAGGVGK-PE |
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGAGGVGK | 8-16 | ４°C | ||||
|
|
TS-M248-1 |
HLA-A*02:01 Insulin Tetramer-ALWGPDPAAA-PE |
|
|||
|
|
Others | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALWGPDPAAA | 15-24 | ４°C | ||||
|
|
TC-8013-2 |
HLA-A*02:01 KRAS5-14 G12C Tetramer-KLVVVGACGV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVVVGACGV | 5-14 | ４°C | ||||
|
|
TC-8014-2 |
HLA-A*11:01 KRAS7-16 WT Tetramer-VVVGAGGVGK-APC |
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAGGVGK | 7-16 | ４°C | ||||
|
|
TS-M270-1 |
HLA-B*07:02 KIF16B Neoepitope Tetramer-APARLERRHSA-PE |
|
|||
|
|
cancer | PE | B*07:02 | 50 tests |
0 (Contact us) |
|
| APARLERRHSA | ４°C | |||||
|
|
TC-8009-1 |
HLA-A*02:01 MAGE-A4286-294 Tetramer-KVLEHVVRV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KVLEHVVRV | 286-294 | ４°C | ||||
|
|
TS-M218-2 |
HLA-A*02:01 ACTN1 Neoepitpe Tetramer-FIASNGVKLV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FIASNGVKLV | ４°C | |||||
|
|
TS-M222-2 |
HLA-A*02:01 NSDHL Neoepitope Tetramer-ILTGLNYEV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILTGLNYEV | ４°C | |||||
|
|
TS-M231-1 |
HLA-A*02:01 GNL3L Neoepitope Tetramer-NLNCCSVPV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| NLNCCSVPV | ４°C | |||||
|
|
TS-M229-1 |
HLA-A*02:01 SNX24 Neoepitope Tetramer-KLSHQLVLL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLSHQLVLL | ４°C | |||||
|
|
TS-M235-2 |
HLA-A*02:01 Filamin-A Neoepitope Tetramer-HIAKSLFEV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| HIAKSLFEV | ４°C | |||||
|
|
TS-M602-1 |
H-2Db LCMV gp Tetramer-CSANNSHHYI-PE |
|
|||
|
|
virus | PE | H-2Db | 50 tests |
0 (Contact us) |
|
| CSANNSHHYI | 92-101 | ４°C | ||||
|
|
TS-M203-1 |
HLA-A*02:01 HPV16 E7 Tetramer-LLMGTLGIV-PE |
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLMGTLGIV | 82-90 | ４°C | ||||
|
|
TC-8008-1 |
HLA-A*02:01 HPV29-38 Tetramer-TIHDIILECV-PE |
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| TIHDIILECV | 29-38 | ４°C | ||||
|
|
TC-8007-1 |
HLA-A*02:01 P53168-176 Tetramer-HMTEVVRRC-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| HMTEVVRRC | 168-176 | ４°C | ||||
|
|
TS-M242-1 |
HLA-A*02:01 MCT2 Neoepitope Tetramer-AMAGSLVFL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| AMAGSLVFL | ４°C | |||||
|
|
TS-M272-2 |
HLA-B*07:02 MLL3 Neoepitope Tetramer-KPSDTPRPVM-APC |
|
|||
|
|
cancer | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| KPSDTPRPVM | ４°C | |||||
|
|
TS-M273-1 |
HLA-B*07:02 TTBK2 Neoepitope Tetramer-RPHHDQRSL-PE |
|
|||
|
|
cancer | PE | B*07:02 | 50 tests |
0 (Contact us) |
|
| RPHHDQRSL | ４°C | |||||
|
|
TS-M207-1 |
HLA-A*02:01 CDK4 Neoepitope Tetramer-ALDPHSGHFV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALDPHSGHFV | ４°C | |||||
|
|
TS-M605-2 |
H-2Dd MCMC M18 Tetramer-SGPSRGRII-APC |
|
|||
|
|
virus | APC | H-2Dd | 50 tests |
0 (Contact us) |
|
| SGPSRGRII | 348-356 | ４°C | ||||
|
|
TS-M236-2 |
HLA-A*02:01 PGM5 Neoepitope Tetramer-QQFAVGSYV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| QQFAVGSYV | ４°C | |||||
|
|
TS-M211-1 |
HLA-A*02:01 HER2 Neoepitope Tetramer-ALIHHNTYL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALIHHNTYL | ４°C | |||||
|
|
TC-8019-1 |
HLA-A*02:01 MAGE-A2112-120 Tetramer-KMVELVHFL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KMVELVHFL | 112-120 | ４°C | ||||
|
|
TS-M611-2 |
H-2Kb β-catenin Tetramer-RTYTYEKL-APC |
|
|||
|
|
Others | APC | H-2Kb | 50 tests |
0 (Contact us) |
|
| RTYTYEKL | 329-336 | ４°C | ||||
|
|
TS-M201-2 |
HLA-A*01:01 TRIP12 Neoepitope Tetramer-PSDTRQMLFY-APC |
|
|||
|
|
cancer | APC | A*01:01 | 50 tests |
0 (Contact us) |
|
| PSDTRQMLFY | ４°C | |||||
|
|
TS-M614-1 |
H-2Kb VPS16 Tetramer-VSFTYRYL-PE |
|
|||
|
|
Others | PE | H-2Kb | 50 tests |
0 (Contact us) |
|
| VSFTYRYL | 227-234 | ４°C | ||||
|
|
TS-M220-1 |
HLA-A*02:01 PRDX5 Neoepitope Tetramer-LLLDDLLVSI-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLLDDLLVSI | ４°C | |||||
|
|
TS-M208-1 |
HLA-A*02:01 p53 Neoepitope Tetramer-VVPCEPPEV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| VVPCEPPEV | ４°C | |||||
|
|
TS-M231-2 |
HLA-A*02:01 GNL3L Neoepitope Tetramer-NLNCCSVPV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| NLNCCSVPV | ４°C | |||||
|
|
TS-M620-1 |
H-2Kb YPEL3 Tetramer-RAYLFNSV-PE |
|
|||
|
|
Others | PE | H-2Kb | 50 tests |
0 (Contact us) |
|
| RAYLFNSV | 47-54 | ４°C | ||||
|
|
TS-M606-2 |
H-2Kb Influenza M1 Tetramer-MGLIYNRM-APC |
|
|||
|
|
virus | APC | H-2Kb | 50 tests |
0 (Contact us) |
|
| MGLIYNRM | 128-135 | ４°C | ||||
|
|
TS-M261-2 |
HLA-A*11:01 MATN2 Neoepitope Tetramer-KTLTSVFQK-APC |
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| KTLTSVFQK | ４°C | |||||
|
|
TS-M207-2 |
HLA-A*02:01 CDK4 Neoepitope Tetramer-ALDPHSGHFV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALDPHSGHFV | ４°C | |||||
|
|
TS-M608-2 |
H-2Kb MCMV M139 Tetramer-TVYGFCLL-APC |
|
|||
|
|
virus | APC | H-2Kb | 50 tests |
0 (Contact us) |
|
| TVYGFCLL | 419-426 | ４°C | ||||
|
|
TS-M622-1 |
H-2Kb STAT3 Tetramer-ATLVFHNL-PE |
|
|||
|
|
Others | PE | H-2Kb | 50 tests |
0 (Contact us) |
|
| ATLVFHNL | 53-60 | ４°C | ||||
|
|
TS-M249-1 |
HLA-A*02:01 APOL1 Tetramer-ALADGVQKV-PE |
|
|||
|
|
Others | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALADGVQKV | 192-200 | ４°C | ||||
|
|
TS-M244-1 |
HLA-A*02:01 FNDC3B Neoepitope Tetramer-VVMSWAPPV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| VVMSWAPPV | ４°C | |||||
|
|
TS-M266-1 |
HLA-A*24:02 COASY Neoepitope Tetramer-RFLEYLPLRF-PE |
|
|||
|
|
cancer | PE | A*24:02 | 50 tests |
0 (Contact us) |
|
| RFLEYLPLRF | ４°C | |||||
|
|
TS-M219-1 |
HLA-A*02:01 SMARCD3 Neoepitope Tetramer-KLFEFLVYGV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLFEFLVYGV | ４°C | |||||
|
|
TS-M225-2 |
HLA-A*02:01 Hsp70 Neoepitope Tetramer-SLFEGIDIYT-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLFEGIDIYT | ４°C | |||||
|
|
TS-M238-1 |
HLA-A*02:01 SNAT1 Neoepitope Tetramer-ILAALFLGL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILAALFLGL | ４°C | |||||
|
|
TS-M221-1 |
HLA-A*02:01 GANAB Neoepitope Tetramer-ALYGFVPVL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALYGFVPVL | ４°C | |||||
|
|
TS-M212-1 |
HLA-A*02:01 CLPP Neoepitope Tetramer-ILDKVLVHL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILDKVLVHL | ４°C | |||||
|
|
TC-8018-2 |
HLA-A*02:01 HBV194-202 Tetramer-FLLTKILTI-APC |
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLLTKILTI | 194-202 | ４°C | ||||
|
|
TS-M238-2 |
HLA-A*02:01 SNAT1 Neoepitope Tetramer-ILAALFLGL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILAALFLGL | ４°C | |||||
|
|
TS-M223-2 |
HLA-A*02:01 TEF-1 Neoepitope Tetramer-VLENFTIFLV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLENFTIFLV | ４°C | |||||
|
|
TS-M277-1 |
HLA-B*08:01 FAM50B Neoepitope Tetramer-DMKARQKALV-PE |
|
|||
|
|
cancer | PE | B*08:01 | 50 tests |
0 (Contact us) |
|
| DMKARQKALV | ４°C | |||||
|
|
TS-M215-1 |
HLA-A*02:01 WDR46 Neoepitope Tetramer-FLIYLDVSV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLIYLDVSV | ４°C | |||||
|
|
TS-M268-1 |
HLA-A*24:02 p53 Tetramer-TYSPALNKMF-PE |
|
|||
|
|
cancer | PE | A*24:02 | 50 tests |
0 (Contact us) |
|
| TYSPALNKMF | 125-134 | ４°C | ||||
|
|
TS-M224-1 |
HLA-A*02:01 CDC37L1 Neoepitope Tetramer-FLSDHLYLV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLSDHLYLV | ４°C | |||||
|
|
TS-M214-1 |
HLA-A*02:01 COL18A1 Neoepitope Tetramer-VLLGVKLFGV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLLGVKLFGV | ４°C | |||||
|
|
TS-M265-1 |
HLA-A*24:02 β-catenin Neoepitope Tetramer-SYLDSGIHF-PE |
|
|||
|
|
cancer | PE | A*24:02 | 50 tests |
0 (Contact us) |
|
| SYLDSGIHF | ４°C | |||||
|
|
TS-M209-2 |
HLA-A*02:01 SRPX Neoepitope Tetramer-TLWCSPIKV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| TLWCSPIKV | ４°C | |||||
|
|
TS-M228-2 |
HLA-A*02:01 PGML5 Neoepitope Tetramer-AVGSYVYSV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| AVGSYVYSV | ４°C | |||||
|
|
TS-M206-2 |
HLA-A*02:01 HCV polyprotein Tetramer-LLFNILGGWV-APC |
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLFNILGGWV | 1807-1816 | ４°C | ||||
|
|
TS-M236-1 |
HLA-A*02:01 PGM5 Neoepitope Tetramer-QQFAVGSYV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| QQFAVGSYV | ４°C | |||||
|
|
TS-M620-2 |
H-2Kb YPEL3 Tetramer-RAYLFNSV-APC |
|
|||
|
|
Others | APC | H-2Kb | 50 tests |
0 (Contact us) |
|
| RAYLFNSV | 47-54 | ４°C | ||||
|
|
TS-M212-2 |
HLA-A*02:01 CLPP Neoepitope Tetramer-ILDKVLVHL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILDKVLVHL | ４°C | |||||
|
|
TS-M227-2 |
HLA-A*02:01 KMT2D Neoepitope Tetramer-ALSPVIPHI-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALSPVIPHI | ４°C | |||||
|
|
TS-M220-2 |
HLA-A*02:01 PRDX5 Neoepitope Tetramer-LLLDDLLVSI-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLLDDLLVSI | ４°C | |||||
|
|
TC-8024-2 |
HLA-A*02:01 KRAS5-14 WT Tetramer-KLVVVGAGGV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVVVGAGGV | 5-14 | ４°C | ||||
|
|
TS-M206-1 |
HLA-A*02:01 HCV polyprotein Tetramer-LLFNILGGWV-PE |
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLFNILGGWV | 1807-1816 | ４°C | ||||
|
|
TC-8020-2 |
HLA-A*02:01 PSMA663-671 Tetramer-MMNDQLMFL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| MMNDQLMFL | 663-671 | ４°C | ||||
|
|
TS-M222-1 |
HLA-A*02:01 NSDHL Neoepitope Tetramer-ILTGLNYEV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILTGLNYEV | ４°C | |||||
|
|
TS-M240-1 |
HLA-A*02:01 CK1α Neoepitope Tetramer-GLFGDIYLAI-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLFGDIYLAI | ４°C | |||||
|
|
TS-M241-2 |
HLA-A*02:01 CK1α Neoepitope Tetramer-GLFGDIYLA-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLFGDIYLA | ４°C | |||||
|
|
TC-M710-1 |
T-Select I-Ab OVA323-339 Tetramer-PE |
|
|||
|
|
OVA | PE | I-Ab | 20 tests | 10 or more | |
| ISQAVHAAHAEINEAGR | 323-339 | ４°C | ||||
- The availability is based on the information in Japan at 00:05, Oct 17, 2026 in JST.
- The special price is shown in red color.
- Please note that products cannot be ordered from this website. To purchase the items listed in this website, please contact us or local distributers.
- For storage temparature: RT: room temparature
- Please note that products in this website might be changed or discontinued without notification in advance for quality improvement.